Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 8Barrett Esophagus 7Gastritis 5Stomach Ulcer 3Peptic Ulcer 3Gastroesophageal Reflux 3Dyspepsia 3Esophageal Neoplasms 2Colorectal Neoplasms 2Zollinger-Ellison Syndrome 1Precancerous Conditions 1Peptic Ulcer Hemorrhage 1Hemorrhage 1Gastrointestinal Stromal Tumors 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Esophagitis, Peptic 1Esophagitis 1Drug-Related Side Effects and Adverse Reactions 1Colonic Neoplasms 1

Interventions

chlorhexidine gluconate 1Omeprazole 1Lansoprazole 1Esomeprazole 1Endoscopy 1Dexlansoprazole 1Clopidogrel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophagitis, Peptic × Esomeprazole × Gastrointestinal × Clear all
NCT00942175 2012-02-03

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Takeda

Phase 1 Completed
160 enrolled 16 charts
Gastrointestinal

Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡